8-K Announcements
6May 15, 2026·SEC
May 14, 2026·SEC
Apr 28, 2026·SEC
P3 Health Partners Inc. (PIII) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's reliance on a $25.5 million cash reserve to sustain a business model with a $649.9 million retained earnings deficit presents an imminent risk of insolvency.
P3 Health Partners Inc. (PIII) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Key metrics vs top competitors for P3 Health Partners Inc. (PIII)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $10.53 | $34.69M | -0.23 | -2.76% | -10.14% | -3183.73% | — | |
| $44.01 | $2.62B | -6.18 | 48.03% | -639.84% | -34.11% | — | |
| $24.05 | $4.91B | -6500.00 | 46.06% | 0.47% | 11.5% | — | |
| $31.12 | $8.07B | -18.41 | 27.5% | -0.3% | -3.26% | — | |
| $66.12 | $32.65B | -4.85 | 19.44% | -3.25% | -28.6% | — | |
| $232.90 | $12.13B | 26.11 | 11.75% | 0.42% | 4.44% | — |
P3 Health Partners Inc. (PIII) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
P3 Health Partners Inc. (PIII) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 15, 2026·SEC
May 14, 2026·SEC
Apr 28, 2026·SEC
Get notified when PIII posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
P3 Health Partners Inc. (PIII) stock FAQ — growth, dividends, profitability & financials explained
P3 Health Partners Inc. (PIII) reported $1.47B in revenue for fiscal year 2025. This represents a 912% increase from $145.5M in 2019.
P3 Health Partners Inc. (PIII) saw revenue decline by 2.8% over the past year.
P3 Health Partners Inc. (PIII) reported a net loss of $126.2M for fiscal year 2025.
P3 Health Partners Inc. (PIII) has a return on equity (ROE) of -3183.7%. Negative ROE indicates the company is unprofitable.
P3 Health Partners Inc. (PIII) had negative free cash flow of $85.2M in fiscal year 2025, likely due to heavy capital investments.